WPRIM Management System> DCMS> Blood Research> 2020> 55> 3

Volume: 55 Issue: 3

1. Successful response with romidepsin in relapsed peripheral T-cell lymphoma, not otherwise specified with leukemic progression Page:175—177
2. Identifying the link between multiple myeloma and neurofibromatosis type I Page:187—189
3. An illustrative case of B-cell prolymphocytic leukemia Page:181—184
4. Nuances in the management of acquired hemophilia A in an elderly patient with large granular lymphocytic leukemia Page:180—181
5. Acute myeloid leukemia with myelodysplasia-related changes and basophilic differentiation Page:130—130
6. Peripheral blood histoplasmosis in an immunocompetent child with disseminated disease Page:129—129
7. Hb-M Hyde Park: a rare cause of cyanosis arising from a de novo mutation Page:177—180
8. Rapid resolution of bone marrow necrosis mimicking relapse of pediatric acute lymphoblastic leukemia Page:184—187
9. Utility of screening tools to differentiate beta thalassemia trait and iron-deficiency anemia - do they serve a purpose in blood donors? Page:169—174
10. Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression Page:131—138
11. Rare bleeding disorders: spectrum of disease and clinical manifestations in the Pakistani population Page:146—150
12. KRAS, NRAS, and BRAF mutations in plasma cell myeloma at a single Korean institute Page:159—168
13. Drug use evaluation of opioid analgesics in pain management among patients with hematopoietic stem cell transplantation Page:151—158
14. Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study Page:139—145

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.